Navigation Links
UNC Lineberger scientists lead definition of key lung cancer genome
Date:9/9/2012

In the September 9, 2012 early online edition of Nature, scientists with The Cancer Genome Atlas (TCGA) report that they have characterized the lung squamous cell carcinoma genome.

Squamous cell carcinoma is the second most common form of lung cancer, a disease that kills more Americans than any other type of cancer.

The national team of scientists examined tumor samples from 178 patients with untreated lung squamous cell carcinoma and completed genetic analysis of the tumors, work that paves the way for developing better, more targeted therapies to treat the cancer.

Neil Hayes, MD, MPH, a UNC investigator with TCGA, explains, "The work confirms the prevalence of commonly known cancer genes such as p53 and p16 in LSCC: alteration of p53 in patients is approaching 100 percent while 70-80 percent of patients have clear alterations of p16. Our report documents a long list of mutations that could be targeted therapeutically, some even now with drugs currently available or in clinical trials."

Dr. Hayes served as co-chair of the manuscript writing committee for the paper. With Matthew Wilkerson, PhD, he served as genomic analysis leader and mRNA sequence analysis. Dr. Hayes is an associate professor of medicine.

He says, "UNC scientists generated all of the microarray and sequencing data on RNA and provided technical expertise in analyzing it. Analyzing gene expression data is very challenging, and UNC brought a large number of collaborators in computer science, statistics, and genetics to help.

"We and all TCGA scientists worked closely together on all aspects of this work," he explains. "Participating institutions provided high-quality tumor samples for the analysis. The study required a wide range of technical expertise to perform all the assays, and no one center could have done it all. "

Putting the study in a scientific context, he explains, "This is like a lot of great science advances. Think back to the late 1700s before it was widely known that many diseases were caused by infections. It's very hard to consider the idea of an antibiotic until you've thought of a germ. We have a disease that's caused by alterations in DNA. It's hard to think about therapies until you know what's wrong with the DNA. In the case of lung cancer, we've made a huge step forward in understanding what's wrong with the DNA of lung cancer."

Co-PI Charles Perou, PhD, says, "This, and other TCGA studies show the powers of a multi-institutional and multi-technological approach. For LSCC, we not only studied the tumor DNA, but also the tumor RNA, with the integration of these data types yielded far more information that either type alone. These data identified numerous new and old drug targets, which is setting the stage for the next generation of clinical trials for LSCC patients." Dr. Perou is the May Goldman Shaw Distinguished Professor of Molecular Oncology.

TCGA is a groundbreaking effort to sequence the entire genome of 20 individual cancers, involving scientists from around the world. UNC Lineberger was one of the original consortium members and will receive over $20 million in grants to fund the research, which extends across multiple types of cancer. TCGA is funded jointly by the National Cancer Institute and the National Human Genome Research Institute, both part of the National Institutes of Health.


'/>"/>
Contact: Dianne G. Shaw
dgs@med.unc.edu
919-966-7834
University of North Carolina Health Care
Source:Eurekalert

Related biology news :

1. University of Alberta medical scientists first in the world to look at structure of vital molecule
2. Scripps Florida scientists design molecule that reverses some fragile X syndrome defects
3. A*STAR scientists discover potential drug for deadly brain cancer
4. Singapore scientists find genes associated with glaucoma, a major cause of eye blindness
5. EARTH: Antarctic trees surprise scientists
6. Rice, MD Anderson scientists probe mystery of operon evolution
7. Coral scientists use new model to find where corals are most likely to survive climate change
8. Scientists call policy-makers to be scale-aware
9. Chinese scientists successfully crack the genome of diploid cotton
10. Scientists find oldest occurrence of arthropods preserved in amber
11. To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)...   Bridge Patient Portal , an enterprise ... EMR Systems , an electronic medical record solutions ... established a partnership to build an interface between ... Centricity™ products, including Centricity Practice Solution (CPS), Centricity ... new integrations will allow healthcare delivery networks using ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions to ... symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory science, ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface ... detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... discussion and webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma (GBM). ... Institute. The event is free and open to the public, but registration is ...
Breaking Biology Technology: